DUBLIN–( SERVICE CORD)– The “Peptide and Oligonucleotide CDMO Market Projection to 2033” has actually been included in ResearchAndMarkets.com’s offering. The international peptide and oligonucleotide CDMO market is experiencing durable development, with its appraisal forecasted to jump from USD 2.80 billion in 2024 to USD 8.14 billion by 2033, accomplishing a CAGR of 12.75% from 2025 to 2033. This development is credited to the rising need for complicated and targeted rehabs, the rise in financial investments in biologics and nucl
发布者：Dr.Durant，转转请注明出处：https://robotalks.cn/peptide-and-oligonucleotide-cdmo-market-to-triple-by-2033-reaching-8-14-billion-analysis-by-product-service-end-use-and-region-featuring-solvay-ensinger-3dxtech-and-more-researchandmarkets-com/
